A medical worker in Beijing. Photo: Greg Baker/AFP via Getty Images

About 150 prescription drugs — including antibiotics, generics and some branded drugs without alternatives — are at risk of shortage if the coronavirus outbreak in China worsens, according to two sources familiar with a list of at-risk drugs compiled by the Food and Drug Administration.

Why it matters: China is a huge supplier of the ingredients used to make drugs that are sold in the U.S. If the virus decreases China's production capability, Americans who rely on the drugs made from these ingredients could be in trouble.

What they're saying: The FDA declined to comment on the list, but said in a statement that it's "keenly aware that the outbreak could impact the medical product supply chain," and has devoted additional resources toward identifying potential vulnerabilities to U.S. medical products stemming specifically from the outbreak.

  • The agency has been in contact with hundreds of drug and medical device manufacturers, and it's also coordinating with global regulators like the European Medicines Agency.
  • It pointed out that there aren't any vaccines, gene therapies or blood derivatives licensed by the FDA that are manufactured in China, although raw materials for many products do come from China and other southeastern Asian countries. The agency is in contact with biologics manufacturers to monitor supply concerns.
  • "If a potential shortage or disruption of medical products is identified by the FDA, we will use all available tools to react swiftly and mitigate the impact to U.S. patients and health care professionals," said an FDA spokesperson.

The intrigue: FDA commissioner Stephen Hahn is not a member of the task force that the administration has assembled to handle the coronavirus. Only two of the dozen members of the task force are physician-scientists, BioCentury noted on Friday.

  • Politico reported Friday night that the White House is worried about how the coronavirus outbreak could shape President Trump's re-election prospects, and some administration officials are concerned that the virus is already spreading within the U.S., undetected.

The bottom line: Whether or not the coronavirus spreads within the U.S., any potential drug shortages would be felt acutely by the American patients that rely on them.

Go deeper: Coronavirus outbreak fuels concerns about pharma's global supply chain

Go deeper

Updated 15 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3 a.m. ET: 10,695,608 — Total deaths: 516,225 — Total recoveries — 5,481,526Map.
  2. U.S.: Total confirmed cases as of 3 a.m. ET: 2,686,582 — Total deaths: 128,062 — Total recoveries: 729,994 — Total tested: 32,827,359Map.
  3. Federal government: Trump says he still thinks coronavirus will "just disappear" at some point, supports another round of direct payments to Americans.
  4. Public health: Thanks to coronavirus, your home is now your gymFormer FDA chief says 500,000 Americans may be contracting coronavirus a day.
  5. States: Georgia and Arizona report record new coronavirus cases — California shuts down bars and indoor dining for most residents.
  6. 1 ⚽️ thing: 6 players test positive for coronavirus before MLS comeback tournament.
Updated 46 mins ago - Health

U.S. daily coronavirus cases top 50,000 for first time

A medical technologist processes test samples for the coronavirus at a lab in Tampa, Florida, on June 25. Photo: Octavio Jones/Getty Images

A record 50,655 tested positive for the novel coronavirus in the United States on Wednesday, Johns Hopkins data shows.

Driving the news: The pandemic is accelerating across the U.S., with the Sun Belt being hit particularly hard. Daily coronavirus case records were reported on Wednesday in Texas (8,076), Arizona (4,878), Georgia (2,946), North Carolina (1,843) and Tennessee (1,806).

Updated 4 hours ago - Politics & Policy

Biden outraises Trump again with record $141 million June haul

Democratic presidential candidate and former Vice President Joe Biden at Philadelphia City Hall in Pennsylvania in June. Photo: Jim Watson/AFP via Getty Images

Former Vice President Joe Biden and the Democratic Party raised $141 million in June, his campaign announced on Wednesday night.

Why it matters: It's the most the presumptive Democratic presidential nominee has raised in a month. It's also more than the record $131 million President Trump's re-election campaign and the Republican National Committee raised last month.